Search Results 571-580 of 2425 for 2024embarking
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care featured image · Mayo Clinic researchers to study causes of ...
Patients' tumors will be sequenced during a pre-registration component or will have had successful sequencing pre-study. A personalized neoantigen peptide ...
In a significant advancement for rare disease research, Mayo Clinic scientists developed a semi-automated system, known as RENEW, to rapidly reanalyze ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The aim of PERKA-812-003 study is to investigate the safety, pharmacokinetics and preliminary anti-tumor activity of treatment with NMS-03597812 as single agent ...
With an aging population and the growth of outpatient electrocardiographic monitoring enabled by smartwatches and other wearable devices, primary care ...
JACKSONVILLE, Fla. — Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year[...] ...
Mayo Clinic researchers made significant strides in 2025 toward predicting, preventing and treating some of the world's most serious and complex diseases.
Changes in how brain cells generate energy may drive the development of Alzheimer's disease and influence how patients respond to therapy, according to a new[..
Vaginal microbiome may predict post-surgery urinary tract infections featured image · Researchers resolve uncertainty in BRCA2 testing, improving cancer risk ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.